Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism: a Randomized, Controlled Trial

NCT05924620 is registered in ClinicalTrials.gov with Chongqing Medical University as lead sponsor.

NCT NCT05924620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05924620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism: a Randomized, Controlled Trial
Lead sponsor
Chongqing Medical University
Phase
Phase 4
Overall status
Completed
Start date
June 21, 2023
Completion date
March 12, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary aldosteronism